Blog

Blog Library

Meet the Evaluate Team: Alex Bour

Alex Bour leads Evaluate’s Competitive Intelligence consulting practice, working closely with clients to help them to understand the nuances of their competitive…

Orphan drugs: about as niche as a flat white

To those beyond the world of biopharma, the term “orphan drug” sounds a bit sad, a bit forgotten. But to those involved in the industry, the superior return on…

Genetic Medicine: The Next Gene-eration

Once upon a time, a gene therapy player could release data on a handful of subjects and see its share price rocket. The sector was riding high after the landmark…